Scientific article
Open access

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours

Published inPloS one, vol. 8, no. 5, e63933
Publication date2013

The feasibility of cancer immunotherapy mediated by T lymphocytes is now a clinical reality. Indeed, many tumour associated antigens have been identified for cytotoxic CD8 T cells, which are believed to be key mediators of tumour rejection. However, for aggressive malignancies in specialised anatomic sites such as the brain, a limiting factor is suboptimal tumour infiltration by CD8 T cells. Here we take advantage of recent advances in T cell biology to differentially polarise CD4 T cells in order to explore their capacity to enhance immunotherapy. We used an adoptive cell therapy approach to work with clonal T cell populations of defined specificity. Th1 CD4 T cells preferentially homed to and accumulated within intracranial tumours compared with Th2 CD4 T cells. Moreover, tumour-antigen specific Th1 CD4 T cells enhanced CD8 T cell recruitment and function within the brain tumour bed. Survival of mice bearing intracranial tumours was significantly prolonged when CD4 and CD8 T cells were co-transferred. These results should encourage further definition of tumour antigens recognised by CD4 T cells, and exploitation of both CD4 and CD8 T cell subsets to optimise T cell therapy of cancer.

Citation (ISO format)
HOEPNER, Sabine et al. Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours. In: PloS one, 2013, vol. 8, n° 5, p. e63933. doi: 10.1371/journal.pone.0063933
Main files (1)
Article (Published version)
ISSN of the journal1932-6203

Technical informations

Creation12/12/2013 10:43:00 PM
First validation12/12/2013 10:43:00 PM
Update time03/14/2023 8:54:32 PM
Status update03/14/2023 8:54:32 PM
Last indexation02/12/2024 11:18:36 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack